Choosing among the incretin agents and why it matters
Unger, J.
Journal of Family Practice 59(5 Suppl): S30-S35
2010
ISSN/ISBN: 1533-7294 PMID: 20544056 Document Number: 642011
Document emailed within 1 workday
Related Documents
Scheen, A.J.; Radermecker, R.P.; Philips, J.C.; Paquot, N. 2007: Incretin mimetics and incretin enhancers for the treatment of type 2 diabetes Revue Medicale Suisse 3(122): 1884; 1886-1888Katsuno, T.; Miyagawa, J.-I. 2012: Therapeutic indications of incretin-related derivatives and other oral hypoglycemic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 3): 693-698
Harada, N.; Inagaki, N. 2010: Incretin and incretin-based therapies Nihon Rinsho. Japanese Journal of Clinical Medicine 68(5): 931-942
Campbell, R.K.; Cobble, M.E.; Reid, T.S.; Shomali, M.E. 2010: Distinguishing among incretin-based therapies. Safety, tolerability, and nonglycemic effects of incretin-based therapies Journal of Family Practice 59(9 Suppl 1: S20-S27
Downie, R 2010: Choosing life, choosing death: the tyranny of autonomy in medical ethics and law Mortality 15(2): 188-189
Nguyen, L.N.; Hahn, P.M.; Jamieson, M.Anne. 2010: Characteristics and concerns of women choosing an online contraception selection tool ("choosing wisely") Journal of Obstetrics and Gynaecology Canada: Jogc 32(8): 763-766
Johansson, B.; Thorvaldsson, V. 2021: What Matters and what Matters Most for Survival After age 80? a Multidisciplinary Exploration Based on Twin Data Frontiers in Psychology 12: 723027
Addy, M. 1995: Evaluation of clinical trials of agents and procedures to prevent caries and periodontal disease: choosing products and recommending procedures International Dental Journal 45(3): 185-196
Blair, K.L.; Pukall, C.F. 2015: Family matters, but sometimes chosen family matters more: Perceived social network influence in the dating decisions of same- and mixed-sex couples The Canadian Journal of Human Sexuality 24(3): 257-270
Sobel, D.S. 2000: MSJAMA: mind matters, money matters: the cost-effectiveness of mind/body medicine JAMA 284(13): 1705
Horsmans, Y.; Larrey, D.; Pessayre, D.; Benhamou, J.P. 1990: Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents Gastroenterologie Clinique et Biologique 14(12): 919-924
Freeman, J.S.; Unger, J. 2008: Why and when to implement incretin therapy Journal of Family Practice 57(9 Suppl): S19-S25
Hada, Y.; Yamauchi, T.; Kadowaki, T. 2010: Incretin related drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 68(10): 1900-1905
Shibasaki, T.; Seino, S. 2011: Regulatory mechanism of incretin secretion Nihon Rinsho. Japanese Journal of Clinical Medicine 69(5): 803-807
Dhungat, J.P. 2017: Gila Monster Lizard and Incretin-mimetics Journal of the Association of Physicians of India 65(4): 96
Whitehill, D. 2007: Treatment of type 2 diabetes mellitus and the incretin system South Dakota Medicine: the Journal of the South Dakota State Medical Association 60(5): 197; 199
Fujita, Y.; Haneda, M. 2011: Molecular mechanism of insulin secretion facilitated by incretin Nihon Rinsho. Japanese Journal of Clinical Medicine 69(5): 808-812
Vilsbøll, T.; Knop, F.K. 2007: Effect of incretin hormones GIP and GLP-1 for the pathogenesis of type 2 diabetes mellitus Ugeskrift for Laeger 169(22): 2101-2105
Brunton, S.A. 2013: Integrating incretin-based therapy into type 2 diabetes management Journal of Family Practice 62(6 Suppl Cme): S1-S8
Unger, J.; Nadeau, D.A. 2007: Defining the role of incretin mimetic therapy in the management of type 2 diabetes Journal of Family Practice 56(12 Suppl New): S4